Carol Rossier Bradford

Carol Rossier Bradford

Auto-generated profile, based on publicly available information

Carol Rossier Bradford

Department of Otolaryngology—Head and Neck Surgery University of Minnesota Medical School Minneapolis Minnesota USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2020 in Head & Neck
Verified
Journal Article
Closed access
PDF file
Luiz P. KowalskiLuiz P. Kowalski
Luiz P. Kowalski
Alvaro SanabriaAlvaro Sanabria
Alvaro Sanabria
JRJohn A Ridge
John A Ridge
WNWai Tong Ng
Wai Tong Ng
Remco De BreeRemco De Bree
Remco De Bree
AFAlfio Ferlito
Alfio Ferlito

10 August 2018 in Cancers
Verified
Journal Article
Open access
PDF file
Marc HamoirMarc Hamoir
Marc Hamoir
SSSandra Schmitz
Sandra Schmitz
CSCarlos Suárez
Carlos Suárez
Primož StrojanPrimož Strojan
Primož Strojan
KHKate A Hutcheson
Kate A Hutcheson
Alfio FerlitoAlfio Ferlito
Alfio Ferlito
Chemoradiotherapy has emerged as a gold standard in advanced squamous cell carcinoma of the head and neck (SCCHN). Because 50% of advanced stage patients relapse after nonsurgical primary treatment, the role of salvage surgery (SS) is critical because surgery is generally regarded as the best treatment option in patients with recurrent resectable SCCHN. Surgeons are increasingly confronted with considering operation among patients with significant effects of failed non-surgical primary treatment. Wide local excision to achieve clear margins must be balanced with the morbidity of the procedure, the functional consequences of organ mutilation, and the likelihood of success. Accurate selection of patients suitable for surgery is a major issue. It is essential to establish objective criteria based on functional and oncologic outcomes to select the best candidates for SS. The authors propose first to understand preoperative prognostic factors influencing survival. Predictive modeling based on preoperative information is now available to better select patients having a good chance to be successfully treated with surgery. Patients with a high comorbidity index, advanced oropharyngeal or hypopharyngeal primary tumors, and both local and regional recurrence have a very limited likelihood of success with salvage surgery and should be strongly considered for other treatments. Following SS, identifying patients with postoperative prognostic factors predicting high risk of recurrence is essential because those patients could benefit of adjuvant treatment or be included in clinical trials. Finally, defining HPV tumor status is needed in future studies including recurrent oropharyngeal SCC patients.

27 January 2020 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
PDF file
CBCarol R. Bradford
Carol R. Bradford
AFAlfio Ferlito
Alfio Ferlito
KDKenneth O. Devaney
Kenneth O. Devaney
AMAntti A. Mäkitie
Antti A. Mäkitie
ARAlessandra Rinaldo
Alessandra Rinaldo
Background: The current treatment results of laryngeal squamous cell carcinoma still remain modest. Various prognostic factors have been investigated and need to be included in the management decision making.Methods: We reviewed the pertinent literature regarding host, tumor, and treatment factors as prognostic indicators that influence outcome in patients diagnosed with laryngeal squamous cell carcinoma.Results: Host, tumor, and treatment factors all have an important impact upon an individual patient's prognosis with laryngeal squamous cell carcinoma, whereas staging systems only take into account tumor factors. There is much work yet to be done to establish reliable, independent biomarkers that predict survival and response to treatment.Conclusions: Optimal outcomes for an individual patient can be achieved when taking into account tumor, host, and treatment factors.

19 July 2011 in Cancer
Verified
Journal Article
Open access
PDF file
AEAudrey B. Erman
Audrey B. Erman
RCRyan M. Collar
Ryan M. Collar
KGKent A. Griffith
Kent A. Griffith
LLLori Lowe
Lori Lowe
MSMichael S. Sabel
Michael S. Sabel
CBCarol R. Bradford
Carol R. Bradford
BACKGROUND: Sentinel lymph node biopsy (SLNB) has emerged as a widely used staging procedure for cutaneous melanoma. However, debate remains around the accuracy and prognostic implications of SLNB for cutaneous melanoma arising in the head and neck, as previous reports have demonstrated inferior results to those in nonhead and neck regions. Through the largest single‐institution series of head and neck melanoma patients, the authors set out to demonstrate that SLNB accuracy and prognostic value in the head and neck region are comparable to other sites.METHODS: A prospectively collected database was queried for cutaneous head and neck melanoma patients who underwent SLNB at the University of Michigan between 1997 and 2007. Primary endpoints included SLNB result, time to recurrence, site of recurrence, and date and cause of death. Multivariate models were constructed for analyses.RESULTS: Three hundred fifty‐three patients were identified. A sentinel lymph node was identified in 352 of 353 patients (99.7%). Sixty‐nine of the 353 (19.6%) patients had a positive SLNB. Seventeen of 68 patients (25%) undergoing completion lymphadenectomy after a positive SLNB result had at least 1 additional positive nonsentinel lymph node. Patients with local control and a negative SLNB failed regionally in 4.2% of cases. Multivariate analysis revealed positive SLNB status to be the most prognostic clinicopathologic predictor of poor outcome; hazard ratio was 4.23 for SLNB status and recurrence‐free survival (P < .0001) and 3.33 for overall survival (P < .0001).CONCLUSIONS: SLNB is accurate and its results are of prognostic importance for head and neck melanoma patients. Cancer 2012;. © 2011 American Cancer Society.

21 November 2019 in Head & Neck
Verified
Journal Article
Closed access
PDF file
APAndres Coca Pelaz
Andres Coca Pelaz
Juan Pablo Rodrigo TapiaJuan Pablo Rodrigo Tapia
Juan Pablo Rodrigo Tapia
CSCarlos Suárez
Carlos Suárez
INIain Nixon
Iain Nixon
AMAntti Mäkitie
Antti Mäkitie
AFAlfio Ferlito
Alfio Ferlito

18 June 2013 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
CBCarol R. Bradford
Carol R. Bradford
BKBhavna Kumar
Bhavna Kumar
EBEmily Bellile
Emily Bellile
JLJulia Lee
Julia Lee
JTJeremy Taylor
Jeremy Taylor
TCThomas Carey
Thomas Carey